Involvement of Trp-284, Val-296, and Val-297 of the human δ-opioid receptor in binding of δ-selective ligands

Manon Valiquette, Huy K. Vu, Shi Yi Yue, Claes R Wahlestedt, Philippe Walker

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Given the high homology in amino acid sequence between the δ-opioid receptor and the two other types (μ and κ), distinct residues in this receptor may confer its selectivity to some ligands. In order to identify molecular determinants in the human δ receptor responsible for the selectivity of δ-selective ligands, two different δ/μ chimeras were constructed. In the first one, the δ sequence from the top of transmembrane 5 to the C terminus was replaced by the equivalent μ sequence, and in the second one, 13 consecutive residues in the third extracellular loop region of the δ receptor were replaced by the μ counterpart. These two chimeras retained the ability to bind the nonselective bremazocine but completely lost the ability to bind different δ-selective ligands. These results suggested that the region of the third extracellular loop of the δ receptor is crucial for the type selectivity. Furthermore, an alanine scan was performed by site- directed mutagenesis of 20 amino acids located in or proximal to the third extracellular loop. Among all the point mutations, only mutations of Trp- 284, Val-296, or Val-297 significantly decreased the binding of δ-selective ligands tested. Moreover, combined mutation of Trp-284, Val-296, and Val-297 considerably decreased the affinities of the receptor for δ-selective ligands compared with the single point mutations. These findings suggest that Trp-284, Val-296, and Val-297 are crucial residues involved in the δ receptor type selectivity.

Original languageEnglish
Pages (from-to)18789-18796
Number of pages8
JournalJournal of Biological Chemistry
Volume271
Issue number31
DOIs
StatePublished - Oct 7 1996
Externally publishedYes

Fingerprint

Opioid Receptors
Ligands
Point Mutation
Amino Acids
Amino Acid Sequence Homology
Mutagenesis
Mutation
Site-Directed Mutagenesis
Alanine

ASJC Scopus subject areas

  • Biochemistry

Cite this

Involvement of Trp-284, Val-296, and Val-297 of the human δ-opioid receptor in binding of δ-selective ligands. / Valiquette, Manon; Vu, Huy K.; Yue, Shi Yi; Wahlestedt, Claes R; Walker, Philippe.

In: Journal of Biological Chemistry, Vol. 271, No. 31, 07.10.1996, p. 18789-18796.

Research output: Contribution to journalArticle

Valiquette, Manon ; Vu, Huy K. ; Yue, Shi Yi ; Wahlestedt, Claes R ; Walker, Philippe. / Involvement of Trp-284, Val-296, and Val-297 of the human δ-opioid receptor in binding of δ-selective ligands. In: Journal of Biological Chemistry. 1996 ; Vol. 271, No. 31. pp. 18789-18796.
@article{9445fdb93ffa4cb2a43d18cbf9333765,
title = "Involvement of Trp-284, Val-296, and Val-297 of the human δ-opioid receptor in binding of δ-selective ligands",
abstract = "Given the high homology in amino acid sequence between the δ-opioid receptor and the two other types (μ and κ), distinct residues in this receptor may confer its selectivity to some ligands. In order to identify molecular determinants in the human δ receptor responsible for the selectivity of δ-selective ligands, two different δ/μ chimeras were constructed. In the first one, the δ sequence from the top of transmembrane 5 to the C terminus was replaced by the equivalent μ sequence, and in the second one, 13 consecutive residues in the third extracellular loop region of the δ receptor were replaced by the μ counterpart. These two chimeras retained the ability to bind the nonselective bremazocine but completely lost the ability to bind different δ-selective ligands. These results suggested that the region of the third extracellular loop of the δ receptor is crucial for the type selectivity. Furthermore, an alanine scan was performed by site- directed mutagenesis of 20 amino acids located in or proximal to the third extracellular loop. Among all the point mutations, only mutations of Trp- 284, Val-296, or Val-297 significantly decreased the binding of δ-selective ligands tested. Moreover, combined mutation of Trp-284, Val-296, and Val-297 considerably decreased the affinities of the receptor for δ-selective ligands compared with the single point mutations. These findings suggest that Trp-284, Val-296, and Val-297 are crucial residues involved in the δ receptor type selectivity.",
author = "Manon Valiquette and Vu, {Huy K.} and Yue, {Shi Yi} and Wahlestedt, {Claes R} and Philippe Walker",
year = "1996",
month = "10",
day = "7",
doi = "10.1074/jbc.271.31.18789",
language = "English",
volume = "271",
pages = "18789--18796",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "31",

}

TY - JOUR

T1 - Involvement of Trp-284, Val-296, and Val-297 of the human δ-opioid receptor in binding of δ-selective ligands

AU - Valiquette, Manon

AU - Vu, Huy K.

AU - Yue, Shi Yi

AU - Wahlestedt, Claes R

AU - Walker, Philippe

PY - 1996/10/7

Y1 - 1996/10/7

N2 - Given the high homology in amino acid sequence between the δ-opioid receptor and the two other types (μ and κ), distinct residues in this receptor may confer its selectivity to some ligands. In order to identify molecular determinants in the human δ receptor responsible for the selectivity of δ-selective ligands, two different δ/μ chimeras were constructed. In the first one, the δ sequence from the top of transmembrane 5 to the C terminus was replaced by the equivalent μ sequence, and in the second one, 13 consecutive residues in the third extracellular loop region of the δ receptor were replaced by the μ counterpart. These two chimeras retained the ability to bind the nonselective bremazocine but completely lost the ability to bind different δ-selective ligands. These results suggested that the region of the third extracellular loop of the δ receptor is crucial for the type selectivity. Furthermore, an alanine scan was performed by site- directed mutagenesis of 20 amino acids located in or proximal to the third extracellular loop. Among all the point mutations, only mutations of Trp- 284, Val-296, or Val-297 significantly decreased the binding of δ-selective ligands tested. Moreover, combined mutation of Trp-284, Val-296, and Val-297 considerably decreased the affinities of the receptor for δ-selective ligands compared with the single point mutations. These findings suggest that Trp-284, Val-296, and Val-297 are crucial residues involved in the δ receptor type selectivity.

AB - Given the high homology in amino acid sequence between the δ-opioid receptor and the two other types (μ and κ), distinct residues in this receptor may confer its selectivity to some ligands. In order to identify molecular determinants in the human δ receptor responsible for the selectivity of δ-selective ligands, two different δ/μ chimeras were constructed. In the first one, the δ sequence from the top of transmembrane 5 to the C terminus was replaced by the equivalent μ sequence, and in the second one, 13 consecutive residues in the third extracellular loop region of the δ receptor were replaced by the μ counterpart. These two chimeras retained the ability to bind the nonselective bremazocine but completely lost the ability to bind different δ-selective ligands. These results suggested that the region of the third extracellular loop of the δ receptor is crucial for the type selectivity. Furthermore, an alanine scan was performed by site- directed mutagenesis of 20 amino acids located in or proximal to the third extracellular loop. Among all the point mutations, only mutations of Trp- 284, Val-296, or Val-297 significantly decreased the binding of δ-selective ligands tested. Moreover, combined mutation of Trp-284, Val-296, and Val-297 considerably decreased the affinities of the receptor for δ-selective ligands compared with the single point mutations. These findings suggest that Trp-284, Val-296, and Val-297 are crucial residues involved in the δ receptor type selectivity.

UR - http://www.scopus.com/inward/record.url?scp=10144241052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10144241052&partnerID=8YFLogxK

U2 - 10.1074/jbc.271.31.18789

DO - 10.1074/jbc.271.31.18789

M3 - Article

C2 - 8702536

AN - SCOPUS:10144241052

VL - 271

SP - 18789

EP - 18796

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 31

ER -